SCHEMBL3849050

SCHEMBL3849050

O=C(N1CCOCC1)N1CCN(c2ccnc3ccc(-c4cn(C(c5ccccc5)(c5ccccc5)c5ccccc5)nc4C(F)(F)F)cc23)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 8/20 0.43
MTOR P42345 2/20 0.39
ALDH1A1 P00352 3/20 0.38
HSD17B10 Q99714 3/20 0.38
KDM4E B2RXH2 3/20 0.38
CYP2C19 P33261 2/20 0.38
HPGD P15428 1/20 0.38
LMNA P02545 1/20 0.38
TP53 P04637 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
ALOX15 P16050 1/20 0.38
TSHR P16473 1/20 0.38
MAPK1 P28482 1/20 0.38
HIF1A Q16665 1/20 0.38
CLK4 Q9HAZ1 1/20 0.38
PDGFRB P09619 3/20 0.38
ACVR1 Q04771 2/20 0.38
BMPR1B O00238 1/20 0.38
KIT P10721 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3846799 0.93 MTOR (0.40) MTORALDH1A1KDM4EHPGDCYP3A4
SCHEMBL3847491 0.91 CYP2C19 (0.45) MTORALDH1A1HSD17B10CYP2C19LMNA
SCHEMBL3846433 0.90 AKR1C3 (0.42) AKR1C3ALDH1A1HSD17B10KDM4ECYP2C19
SCHEMBL3850111 0.87 MTOR (0.39) MTORALDH1A1KDM4EMAPK1PDGFRB
SCHEMBL3846231 0.84 MAPKAPK2 (0.46) ALDH1A1HSD17B10KDM4ECYP2C19HPGD
SCHEMBL3848141 0.84 CYP3A4 (0.50) MTORALDH1A1HSD17B10KDM4EHPGD
SCHEMBL3850354 0.83 NCF1 (0.48) MTORALDH1A1CYP2C19LMNACYP1A2
SCHEMBL3845802 0.80 CTSS (0.37) MTORALDH1A1KDM4ECYP2C19CYP1A2
SCHEMBL3847156 0.80 AKR1C3 (0.43) AKR1C3MTORALDH1A1HSD17B10KDM4E
SCHEMBL3844619 0.79 MAPKAPK2 (0.40) PIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed